Ā | Crude | Adjusted | ||
---|---|---|---|---|
sHRa(95%C.I.) | p-value | sHRa(95%C.I.) | p-value | |
Cancer vs. Non-cancer | 0.92 (0.64ā1.32) | 0.6374 | 0.91 (0.63ā1.31) | 0.6089 |
Comorbidities | ||||
āMyocardial infarct | 1.58 (0.74ā3.36) | 0.2355 | 1.47 (0.68ā3.18) | 0.3334 |
ācongestive heart failure | 1.18 (0.77ā1.79) | 0.4473 | 1.07 (0.70ā1.64) | 0.7466 |
āperipheral vascular | 1.42 (0.73ā2.78) | 0.3036 | 1.33 (0.68ā2.63) | 0.4084 |
ācerebrovascular disease | 1.22 (0.87ā1.69) | 0.2500 | 1.08 (0.76ā1.53) | 0.6857 |
ādementia | 1.79 (0.92ā3.51) | 0.0874 | 1.63 (0.82ā3.24) | 0.1631 |
āchronic lung disease | 1.17 (0.88ā1.55) | 0.2827 | 1.11 (0.82ā1.50) | 0.4975 |
āconnective tissue disease | 1.06 (0.63ā1.80) | 0.8218 | 1.05 (0.62ā1.78) | 0.8579 |
āUlcer | 1.10 (0.83ā1.46) | 0.5153 | 1.03 (0.77ā1.38) | 0.8437 |
āchronic liver disease | 1.09 (0.75ā1.59) | 0.6491 | 1.07 (0.73ā1.57) | 0.7438 |
āDiabetes | 1.14 (0.84ā1.54) | 0.4175 | 0.99 (0.71ā1.40) | 0.9698 |
ādiabetes with end organ damage | 1.77 (1.03ā3.06) | 0.0401 | 1.67 (0.91ā3.06) | 0.1007 |
āHemiplegia | 1.52 (0.48ā4.80) | 0.4733 | 1.28 (0.40ā4.12) | 0.6779 |
āmoderate or severe kidney disease | 1.12 (0.67ā1.87) | 0.6631 | 1.07 (0.64ā1.79) | 0.7902 |
āModerate or severe liver disease | ā | Ā | ā | Ā |
āAIDS | .- | Ā | ā | Ā |
āChemotherapy | 0.96 (0.54ā1.72) | 0.8913 | 0.99 (0.47ā2.09) | 0.9815 |
āMetastasis | 8.66 (1.24ā60.50) | 0.0296 | 10.13 (1.19ā86.34) | 0.0343 |